Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
With novel payload categories such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, and splice modulators entering the clinic, don't miss this opportunity to meet with ...
TL;DR: Given a 3D semantic layout, SpatialGen can generate a 3D indoor scene conditioned on either a reference image (left) or a textual description (right) using a multi-view, multi-modal diffusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback